{"entity":{"id":"f27fb560-ac80-5f57-aada-2abf63da4070","name":"Samsara BioCapital GP, LLC","type":"Person","kind":"person","jurisdiction":"US","identifier":"sec:0001888829","risk":"LOW","flags":[]},"identity":{"linked_records":[],"also_known_in":[]},"ownership":{"direct_owners":[],"holdings":[{"role":"10% owner","share":null,"asset":{"id":"de4c956a-976e-5209-89f2-2f72662ee99d","name":"Kalaris Therapeutics, Inc.","type":"Company","kind":"company"}},{"role":"10% owner","share":null,"asset":{"id":"ce1db34b-b2dd-51bb-8605-d58190624d9b","name":"Mineralys Therapeutics, Inc.","type":"Company","kind":"company"}}],"ubo_chain":[]},"risk":{"level":"LOW","flags":[],"note":"Risk is a layer-1 signal (offshore-layering / connectivity heuristics) — an investigative lead, not a determination."},"sources":[{"registry":"sec_edgar","source_url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001888829"}],"source":"corpus"}